dc.creator | Tresguerres F.G.F. | |
dc.creator | Torres J. | |
dc.creator | López-Quiles J. | |
dc.creator | Hernández G. | |
dc.creator | Vega J.A. | |
dc.creator | Tresguerres I.F. | |
dc.date.accessioned | 2020-09-02T22:29:24Z | |
dc.date.accessioned | 2022-11-08T20:18:35Z | |
dc.date.available | 2020-09-02T22:29:24Z | |
dc.date.available | 2022-11-08T20:18:35Z | |
dc.date.created | 2020-09-02T22:29:24Z | |
dc.date.issued | 2020 | |
dc.identifier | 227, , - | |
dc.identifier | 09409602 | |
dc.identifier | https://hdl.handle.net/20.500.12728/6440 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5142780 | |
dc.language | en | |
dc.publisher | Elsevier GmbH | |
dc.subject | Bone remodeling | |
dc.subject | FGF-23 | |
dc.subject | Osteocyte | |
dc.subject | Sclerostin | |
dc.subject | beta catenin | |
dc.subject | bisphosphonic acid derivative | |
dc.subject | blosozumab | |
dc.subject | calcium | |
dc.subject | cell marker | |
dc.subject | connexin 43 | |
dc.subject | denosumab | |
dc.subject | dickkopf 1 protein | |
dc.subject | fibroblast growth factor 23 | |
dc.subject | glycogen synthase kinase 3 | |
dc.subject | Hermes antigen | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | low density lipoprotein receptor related protein 5 | |
dc.subject | low density lipoprotein receptor related protein 6 | |
dc.subject | matrix metalloproteinase 14 | |
dc.subject | osteocalcin | |
dc.subject | osteoclast differentiation factor | |
dc.subject | osteoprotegerin | |
dc.subject | parathyroid hormone | |
dc.subject | parathyroid hormone receptor 1 | |
dc.subject | parathyroid hormone related protein | |
dc.subject | parathyroid hormone[1-34] | |
dc.subject | phosphate | |
dc.subject | prostaglandin E2 | |
dc.subject | protein E11 | |
dc.subject | receptor activator of nuclear factor kappa B | |
dc.subject | romosozumab | |
dc.subject | sclerostin | |
dc.subject | unclassified drug | |
dc.subject | unindexed drug | |
dc.subject | Wnt protein | |
dc.subject | calcium | |
dc.subject | aging | |
dc.subject | apoptosis | |
dc.subject | atypical femur fracture | |
dc.subject | atypical subtrochanteric femur fracture | |
dc.subject | autocrine effect | |
dc.subject | autophagy | |
dc.subject | bone age | |
dc.subject | bone density | |
dc.subject | bone disease | |
dc.subject | bone fragility | |
dc.subject | bone linning cell | |
dc.subject | bone loss disorder | |
dc.subject | bone marrow cell | |
dc.subject | bone mass | |
dc.subject | bone matrix | |
dc.subject | bone mineralization | |
dc.subject | bone multicellular unit | |
dc.subject | bone necrosis | |
dc.subject | bone remodeling | |
dc.subject | bone structure | |
dc.subject | bone tissue | |
dc.subject | bone tumor | |
dc.subject | bone turnover | |
dc.subject | calcium blood level | |
dc.subject | calcium transport | |
dc.subject | cancer prevention | |
dc.subject | cell activity | |
dc.subject | cell body | |
dc.subject | cell communication | |
dc.subject | cell damage | |
dc.subject | cell death | |
dc.subject | cell differentiation | |
dc.subject | cell function | |
dc.subject | cell maturation | |
dc.subject | cell stimulation | |
dc.subject | cell surface | |
dc.subject | cell transformation | |
dc.subject | cell viability | |
dc.subject | cells by body anatomy | |
dc.subject | cellular distribution | |
dc.subject | cellular secretion | |
dc.subject | chronic kidney disease mineral bone disorder | |
dc.subject | chronic kidney failure | |
dc.subject | cortical bone | |
dc.subject | drug activity | |
dc.subject | effector cell | |
dc.subject | endocrine cell | |
dc.subject | enzyme inhibition | |
dc.subject | extracellular matrix | |
dc.subject | femur fracture | |
dc.subject | femur subtrochanteric fracture | |
dc.subject | fracture nonunion | |
dc.subject | gap junction | |
dc.subject | gene | |
dc.subject | gene expression | |
dc.subject | genetic transcription | |
dc.subject | human | |
dc.subject | incidence | |
dc.subject | ischemia | |
dc.subject | jaw osteonecrosis | |
dc.subject | lacunocanalicular system | |
dc.subject | mechanosensory cell | |
dc.subject | mechanotransduction | |
dc.subject | mesenchymal stem cell | |
dc.subject | microenvironment | |
dc.subject | mineral metabolism | |
dc.subject | nonhuman | |
dc.subject | ossification | |
dc.subject | osteoblast | |
dc.subject | osteoclast | |
dc.subject | osteoclastogenesis | |
dc.subject | osteocyte | |
dc.subject | osteoid | |
dc.subject | osteolysis | |
dc.subject | osteoporosis | |
dc.subject | paracrine signaling | |
dc.subject | pathologic fracture | |
dc.subject | pathophysiology | |
dc.subject | phosphate metabolism | |
dc.subject | porosity | |
dc.subject | postmenopause osteoporosis | |
dc.subject | prophylaxis | |
dc.subject | protein degradation | |
dc.subject | protein expression | |
dc.subject | protein function | |
dc.subject | protein localization | |
dc.subject | protein phosphorylation | |
dc.subject | protein protein interaction | |
dc.subject | protein secretion | |
dc.subject | protein synthesis | |
dc.subject | protein transport | |
dc.subject | regulatory mechanism | |
dc.subject | Review | |
dc.subject | SOST gene | |
dc.subject | trabecular bone | |
dc.subject | trabecular microcrack | |
dc.subject | treatment duration | |
dc.subject | blood | |
dc.subject | bone | |
dc.subject | bone development | |
dc.subject | cytology | |
dc.subject | mechanoreceptor | |
dc.subject | osteocyte | |
dc.subject | physiology | |
dc.subject | Apoptosis | |
dc.subject | Bone and Bones | |
dc.subject | Bone Remodeling | |
dc.subject | Bone Resorption | |
dc.subject | Calcium | |
dc.subject | Endocrine Cells | |
dc.subject | Humans | |
dc.subject | Mechanoreceptors | |
dc.subject | Mechanotransduction, Cellular | |
dc.subject | Osteocytes | |
dc.subject | Osteogenesis | |
dc.title | The osteocyte: A multifunctional cell within the bone | |
dc.type | Review | |